Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 1, 2006, Pages 48-49

  Pasic, Srdjan ^a,b   Vujic, Dragana ^a   Djuricic, Slavisa ^a   Jevtic, Dragana ^a   Grujic, Blagoje ^a  

^a Mother and Child Health Institute of Serbia Dr Vukan Cupic   (Yugoslavia)

^b Mother and Child Health Institute   (Yugoslavia)

Author keywords

Burkitt lymphoma; Ileocolic intussusception; Wiskott Aldrich syndrome

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL PAIN; ARTICLE; BURKITT LYMPHOMA; CANCER REGRESSION; CASE REPORT; CHILD; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEOCOLIC INTUSSUSCEPTION; ILEUM RESECTION; IMMUNOHISTOCHEMISTRY; INTESTINE INTUSSUSCEPTION; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; SURGICAL APPROACH; TISSUE SECTION; WISKOTT ALDRICH SYNDROME; ILEUM DISEASE; INTUSSUSCEPTION; PATHOLOGY;

BURKITT LYMPHOMA; CHILD; HUMANS; ILEAL DISEASES; INTUSSUSCEPTION; MALE; WISKOTT-ALDRICH SYNDROME;

EID: 33644845415     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wiskott A. Familiarer, angeborener Morbus Werlhofii? Monatschrift Kinderheilkunde. 1937;68:212-216.
2. Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133-139.
3. Filipovich AH, Mathur A, Kamat D, et al. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency. 1994;5:91-112.
4. Sullivan KE, Mullen CA, Blaese RM, et al. A multiinstitutional survey of Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876-885.
5. Stewart DM, Treiber-Held S, Kurman CC, et al. Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest. 1996;97:2627-2634.
6. Murphy SB. Classification, staging and results of treatment in childhood non-Hodgkin lymphoma: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-339.
7. Conley ME, Saragoussi D, Notarangelo LD, et al. An international study examining therapeutic options in treatment of Wiskott-Aldrich syndrome. Clin Immunol. 2003;109:272-277.
8. Litzman J, Jones A, Hann I, et al. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75:436-439.
9. Mueller B, Pizzo PA. Cancer in children with primary or secondary immunodeficiencies. J Pediatr. 1995;126:1-9.
10. Müller H. Recessively inherited deficiencies predisposing to cancer. Anticancer Res. 1990;10:513-518.
11. Cotelingam JD, Witebsky FG, Hsu MS, et al. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest. 1985;3:515-522.
12. Frizzera G, Rosni J, Dehner LP, et al. Lymphoreticular disorders in primary immunodeficiencies. New findings based on up-to-date histologic classification of 35 cases. Cancer. 1980;46:692-699.
13. Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.